OPRX — OptimizeRx Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyAdventurousSmall CapNeutral

Annual balance sheet for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18.9	10.5	84.7	74.1	13.9
Net Total Accounts Receivable
Net Total Receivables	7.42	17.9	24.8	22.2	37.3
Prepaid Expenses
Total Current Assets	27.1	32.9	115	98.6	54.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.736	0.595	0.473	0.373	0.722
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	56.6	60.3	141	135	183
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.11	10	9.37	8.4	17.9
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	11.8	10.4	9.61	8.54	56.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	44.9	50	131	126	127
Total Liabilities & Shareholders' Equity	56.6	60.3	141	135	183
Total Common Shares Outstanding